NurExone Biologic Inc. Stock Deutsche Boerse AG
Equities
J90
CA67059R1091
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.469 EUR | +4.22% |
|
-4.74% | +158.48% |
05-29 | NurExone Biologic Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-25 | NurExone Biologic Announces OTCQB Listing And DTC Eligibility | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 35.48M 32.82M 48.29M |
---|---|---|---|---|---|
Net income 2024 * | -4M -3.7M -5.44M | Net income 2025 * | -4M -3.7M -5.44M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.6
x | P/E ratio 2025 * |
-6.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.91% |
1 day | +4.22% | ||
1 week | -4.74% | ||
Current month | +0.45% | ||
1 month | +38.12% | ||
3 months | -5.56% | ||
6 months | +156.98% | ||
Current year | +158.48% |
![Extreme 0.42](/images/extremecours_fleche.png)
![Extreme 0.282](/images/extremecours_fleche.png)
![Extreme 0.167](/images/extremecours_fleche.png)
![Extreme 0.104](/images/extremecours_fleche.png)
![Extreme 0.104](/images/extremecours_fleche.png)
![Extreme 0.104](/images/extremecours_fleche.png)
![Extreme 0.104](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Lior Shaltiel
CEO | Chief Executive Officer | - | 21-03-31 |
Eran Ovadya
DFI | Director of Finance/CFO | - | 22-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Richardson
BRD | Director/Board Member | 78 | 22-01-02 |
Gadi Riesenfeld
BRD | Director/Board Member | 79 | 23-07-05 |
Yoram Drucker
CHM | Chairman | 59 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-04 | 0.442 | -1.78% | 0 |
24-07-03 | 0.45 | +3.21% | 8,500 |
24-07-02 | 0.436 | +3.81% | 0 |
24-07-01 | 0.42 | -4.55% | 50 |
24-06-28 | 0.44 | -5.17% | 12,800 |
Delayed Quote Deutsche Boerse AG, July 04, 2024 at 02:18 am
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.59% | 44.44B | |
+41.02% | 39.84B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.23% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- NRX Stock
- J90 Stock